Pharmaceutical Technology

JUNE 30, 2025

How will RFK Jr’s American dream for vaccines play out? Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. This update also suggests we may not see REMS requirements for CD19 and BCMA autologous CAR-T cell therapies in the future,” the research note added. You will receive an email shortly.

Insurance Coverage and Processing

Pharmacy Times

JULY 25, 2025

Insurance coverage for GLP-1 medications can be a barrier, as they are often not covered for non-diabetic uses, necessitating pharmacist guidance. These patients, the investigators noted, presented a more severe obesity compared with patients who responded more positively.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 9, 2025

How will RFK Jr’s American dream for vaccines play out? Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. JCR has also developed a proprietary blood-brain barrier-penetrating technology, J-Brain Cargo, to deliver biotherapeutics into the central nervous system. You will receive an email shortly.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? The company is confident that these concerns, which pertain to facilities and processes rather than product quality, can be promptly addressed. The FDA has recognised that the neurodevelopmental outcome data presented so far are robust. You will receive an email shortly.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 16, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and gene therapy industries, the current state of the market, present and future opportunities for advancement, and the challenges that lie ahead.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 30, 2025

Robert Barrie July 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Prasad, an oncologist who was a fierce critic of the Covid-19 vaccine response in the US, was appointed only three months ago. Prasad, an oncologist who was a fierce critic of the Covid-19 vaccine response in the US, was appointed only three months ago.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 17, 2025

How will RFK Jr’s American dream for vaccines play out? Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 20, 2025

Unlike vaccines, the agency leaders see the modality as a path to prevent and cure disease – aligning with the current administration’s wider national health strategy. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

BioPharma Dive

JULY 31, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Vaccines Experts ousted from CDC panel warn of damage to US vaccine policy The 17 advisers fired last month by Robert F. vaccine policymaking process.” Kennedy Jr.

Vaccines

Express Pharma

JANUARY 12, 2024

Initiatives such as Ayushmaan Bharat Digital Mission (“ADBDM”), CoWIN (a digital vaccine delivery platform), health registry, and telemedicine, highlight the government’s strong emphasis on digitisation of health in India. For pharma and medical devices policies, the Department of Pharmaceutical is the nodal agency. –

Insurance Coverage and Processing

Putting Patients First Blog

APRIL 29, 2024

Communication and Transparency Clear Communication : We emphasize the need for documents to clearly and effectively communicate the nuances of the MPPP to beneficiaries, aiding in their decision-making process.

Documentation

The Happy PharmD

SEPTEMBER 15, 2024

This annual report presents insights gleaned from over 79,000 Well-Being Index assessments conducted in 2023, with a particular emphasis on the 2,584 assessments completed by pharmacists. Or perhaps it’s the constant back-and-forth with insurance companies over coverage? Share your thoughts down below!

Insurance Coverage and Processing

Putting Patients First Blog

SEPTEMBER 9, 2024

15, which enhances standards for collecting and presenting race and ethnicity data across federal agencies, CMS should ensure that its data collection efforts are inclusive and representative of all Medicare beneficiaries. CY 2025 PFS proposed rule). In line with the recent revisions to OMB’s Statistical Policy Directive No.

Insurance Coverage and Processing